Statistical analysis showed significant up-regulation of NR3C1 gene in MS patients compared with healthy controls (P=0.03), and in male subgroup compared with the corresponding age and sex-matched healthy subjects (P = 0.001). Here, NR3C1 is linked to myeloid sarcoma.